The success of Sildenafil initially fueled a boom for the drug industry, but recent shifts present a murky outlook for investors. Generic alternatives are reducing earnings, and persistent legal battles add additional https://saadruwf788997.topbloghub.com/47756856/the-blue-pill-and-pharma-a-volatile-investment